Latest Form 4 insider transactions

NASDAQ
Anshul Maheshwari, Chief Op & Financial Officer of SI-BONE, Inc., sold 5,049 shares of common stock on October 2, 2026.
NYSE
Stephen Preston, Chairman, CEO and President and a Director of FrontView REIT, Inc., reported multiple transactions in common stock on October 4, 2026.
Claude Leblanc, Chief Executive Officer and a Director of Ambac Financial Group Inc, reported multiple transactions in common stock on October 3, 2026.
R Sharon Smith, Exec VP & Group COO of Ambac Financial Group Inc, reported multiple transactions in common stock on October 3, 2026.
NASDAQ
Joseph Gates Clark, SVP and Pres, Optimized LED of Penguin Solutions, Inc., reported multiple transactions in common stock on October 3, 2026.
David Trick, Exec VP, CFO & Treasurer of Ambac Financial Group Inc, reported multiple transactions in common stock on October 3, 2026.
NYSE
Kyle Clark, SEE REMARKS and a Director of BETA Technologies, Inc., sold 30,000 shares of common stock on October 2, 2026.
NYSE
Ana G. Pinczuk, President Product & Technology and a Director of SentinelOne, Inc., sold 16,042 shares of common stock on October 6, 2026 for $25.33 per share.
NYSE
Barry L. Padgett, President and COO of SentinelOne, Inc., sold 15,460 shares of common stock on October 6, 2026 for $25.33 per share.
NYSE
Sonalee Elizabeth Parekh, Chief Financial Officer of SentinelOne, Inc., sold 51,703 shares of common stock on October 6, 2026 for $25.33 per share.
NYSE
Tomer Weingarten, President, CEO and a Director of SentinelOne, Inc., sold 527,368 shares of common stock on October 5, 2026 for $25.26 per share.
NYSE
Paul P. Rusnak, a 10% owner of Sonic Automotive Inc, purchased 27,756 shares of common stock on October 5, 2026 for $59.76 per share.
NASDAQ
Eugene Scott Crist, a Director of Arbe Robotics Ltd., purchased 50,000 shares of common stock on September 28, 2026 for $0.60 per share.
NYSE
Mark E Lashier, a Director of Motorola Solutions, Inc., received 62 shares of common stock on October 2, 2026.
NYSE
Fumihide Esaka, Chief Executive Officer and a Director of Ambiq Micro, Inc., sold 16,560 shares of common stock on October 2, 2026.
NASDAQ
William Chan, Chief Product & AI Officer of Waystar Holding Corp., reported a transaction in 9,560 shares of common stock on October 5, 2026.
NYSE
Scott Mclean Hanson, Chief Technology Officer and a Director of Ambiq Micro, Inc., sold 8,680 shares of common stock on October 2, 2026.
NYSE
Sean Chihhsiang Chen, President and COO of Ambiq Micro, Inc., sold 14,007 shares of common stock on October 2, 2026.
NYSE
David P. Mcquarrie, Chief Commercial Officer of Hp Inc, sold 31,572 shares of common stock on October 2, 2026 for $32.12 per share.
Anthony Mathew Eisen, a Director of Block, Inc., sold 18,000 shares of common stock on October 2, 2026.
NASDAQ
Fred Joseph Deutsch, a Director of First Community Corp /Sc/, sold 0 shares of common stock on October 5, 2026 for $32.57 per share.
NASDAQ
Scott G. Davis, a Director of Ekso Bionics Holdings, Inc., received 51,626 shares of common stock on October 2, 2026.
OQB
Scott M. Pittman, a Director and 10% owner of Nuo Therapeutics, Inc., reported multiple transactions in common stock on October 6, 2026.
NYSE
Ravi Kumaraswami, Pres. Worldwide Field Ops. of Riskified Ltd., reported a transaction in 62,581 shares of common stock on October 5, 2026.
NYSE
Aglika Dotcheva, Chief Financial Officer of Riskified Ltd., reported a transaction in 60,487 shares of common stock on October 5, 2026.
NYSE
Assaf Feldman, Chief Strategy Officer - Tech, a Director and 10% owner of Riskified Ltd., reported a transaction in 10,975 shares of common stock on October 5, 2026.
NYSE
Eido Gal, Chief Executive Officer, a Director and 10% owner of Riskified Ltd., reported a transaction in 34,391 shares of common stock on October 5, 2026.
De Lima Filho Pedro Batista, a Director of Brazilian Electric Power Co, purchased 489,900 shares of common stock on October 2, 2026 for $10.81 per share.
NYSE
Thomas Williams, a Director of Sherwin Williams Co, received 104 shares of common stock on October 2, 2026.
NASDAQ
Barry J. Simon, a Director of ImmunityBio, Inc., sold 25,000 shares of common stock on October 5, 2026 for $10.75 per share.